ArticleNeuropsychiatric disease and treatment2026
Predictive Factors of Low HDL-C in Patients with Schizophrenia.
Article in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Schizophrenia patients engage in more sedentary life activities and endure a higher risk of metabolic syndrome than general population. Evidence on investigating the predictors in relation to low HDL-C in schizophrenia is still lacking. Methods: This cross-sectional study recruited 133 schizophrenia patients from a tertiary hospital; 13 patients were not included (12 refused participation and 1 had missing data). Blood samples were collected to determine plasma levels of total cholesterol, triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol. Atherogenic index of plasma was calculated using log10(TG/HDL-C). The physical capacity was measured by 6-minute walk test (6MWT). The group of low HDL-C was categorized according to the sex-specific HDL-C thresholds (male: < 40 mg/dL; female: < 50 mg/dL); the reference category was the group of normal HDL-C. Three logistic regression models were performed to identify if sex, hospitalization times, 6MWT distances and TG levels were the significant predictors of low HDL-C. We examined the model performances using the area under the receiver operating characteristics curve (AUC) and calculated accuracy, sensitivity and specificity. Results: Model 1 (AUC = 0.79, accuracy/sensitivity/specificity = 0.73/0.60/0.81) and Model 2 (AUC = 0.82, accuracy/sensitivity/specificity = 0.75/0.66/0.81) controlled without or with education years. Model 3 (AUC = 0.82, accuracy/sensitivity/specificity = 0.76/0.64/0.84) controlled educational years, height and body mass index and showed relatively optimal accuracy and specificity with similar performance of Model 2. All models found that female, hospitalization times, 6MWT distances and TG levels were significant predictors associated with low HDL-C after multiple comparisons (all Conclusion: The results provide the clinical importance to assess low HDL-C, especially for female schizophrenia with more hospitalization, shorter 6MWT distances or higher TG levels due to increased susceptibility to cardiometabolic risks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.